Assessment of Aminoglycoside-Induced Hearing Loss Risk in the Perinatal Period.
Whitney S ThompsonLeslie SabaLinda HasadsriSylvie GirardLisa A SchimmentiEllen M Bendel-StenzelMyra J WickJane E BrumbaughPublished in: American journal of perinatology (2024)
· MT-RNR1 variants are associated with aminoglycoside-induced hearing loss.. · Prevalence of MT-RNR1 variants is uncertain.. · Universal screening for MT-RNR1 variants may be indicated..